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Targeting black mamba α-neurotoxins with nanobodies
Feared for its highly neurotoxic venom and rapid attack technique, the Black mamba
(Dendroaspis polylepis) is Africa’s largest venomous snake [1]. The clinical manifestations of a bite
from D. polylepis include flaccid paralysis leading to respiratory failure and death due to post-
synaptic blockade of the neuromuscular junctions caused by α-neurotoxins [1-4]. Since
antivenoms suffer from a reactivity bias towards larger toxins due the fact that antivenoms are
produced by immunization of large mammals, current antivenoms could be reinforced by addition
of monoclonal antitoxins directed towards the smaller α-neurotoxins [1,5]. Here, we report the
discovery of selective nanobodies targeting α-elapitoxin Dpp2c from D. polylepis through phage
display screening [6].
Results – two selective nanobody binders discovered
A M13 phage library displaying nanobody genes from a llama immunized with venom from the
monocled cobra (Naja kaouthia) [7,8] was selected against a venom fraction from D. polylepis
venom containing high amounts of α-elapitoxin Dpp2c. Two monoclonal phages that bound
strongly to this fraction were isolated. Monoclonal phage DNA will soon be sequenced, which will
unveil the primary structure of the nanobodies displayed on the phages.
Outlook – Reinforcing antivenoms with nanobodies
The isolated monoclonal nanobody displaying phages showed great selectivity towards α-
elapitoxin Dpp2c and could potentially be added to existing antivenoms to reinforce their
response towards this lethal α-neurotoxin. Once the sequences of the displayed nanobodies is
known, the next steps include biosynthesis, determination of binding constants for the
nanobodies, and measurement of their ability to inhibit α-elapitoxin Dpp2c in vitro and in vivo.
Figure 1: Dendroaspis polylepis (Black mamba) eating prey. Photo: Ted Arensmeier 2007
Figure 2: ELISA results. The polyclonal phage library from the third round of panning yields a
strong ELISA signal, indicating the presence of strong peptide binders to α-elapitoxin Dpp2c
α-elapitoxin Dpp2c Overlay of α-elapitoxin Dpp2c and α-Cbt
Figure 3: ELISA results for 10 selected phage monoclones against α-elapitoxin Dpp2c.
Figure 5: Cartoon model of α-elapitoxin Dpp2c compared with overlaid cartoon models of α-
elapitoxin Dpp2c and α-cobratoxin from Naja kaouthia (α-Cbt, cyan), drawn in PyMOL. 
Sequence alignment short neurotoxin I (SNT-I), α-elapitoxin Dpp2c (Dpp2c), and muscarinic 
toxin-α (MT-α), which are all α-neurotoxins from D. polylepis.
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SNT-I| RICYNHQSTTRATTKSCE--ENSCYKKYWRD----HRGTIIERGCG--CPKVKPG-VGIHCCQSDKCNY------- 60
Dpp2c| RTCNKTPSDQ---SKICPPGENICYTKTWCDAWCSQRGKIVELGCAATCPKVKAG-VEIKCCSTDNCNKFKFGKPR 72
MT-α | LTCVTSKSIFGITTENCPDGQNLCFKKWYYLN---HRYSDITWGCAATCPKPTNVRETIHCCETDKCNE------- 66
* .  *     :: *   :* *:.* :      :* . :  **.  **** .     *:**.:*:**
Figur 4: ELISA-based cross-reactivity study of the nanobody-displaying isolated phages. 
Dppc2: α-elapitoxin Dpp2c, SN-I: Short neurotoxin I, α-Cbt: α-cobratoxin.
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